By clinicians for clinicians
It all started in December 2013. After 2 years of research and development supported by the Centre of Technological Resources in Chemistry, Certech (Belgium), the founders Eric Rompen, France Lambert and Geoffrey Lecloux together established Wishbone SA. Together with The Faktory, a private seed investment fund, incubator and accelerator based in Liège, Wishbone set up their production and process development facility in Flémalle.
The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone.